SCHEMBL26408558

CC[C@H]1C[C@@H](C(=O)NCCNC(=O)NCCNC(=O)[C@@H]2C[C@H](CC)[C@@H](O[C@@H]3O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]3O)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC4CCCCC4)C(=O)O)[C@H]3NC(C)=O)C2)C[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2NC(C)=O)[C@@H]1O[C@@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.81

Predicted protein targets (top 1)

	gene	UniProt	supporting neighbours	confidence
▸	SELE	P16581	19/20	0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL17151665	0.96	SELE (0.80)	SELE
SCHEMBL23943286	0.95	SELE (0.90)	SELE
SCHEMBL22006658	0.95	SELE (0.84)	SELE
SCHEMBL25562384	0.95	SELE (0.84)	SELE
SCHEMBL19508734	0.94	SELE (0.79)	SELE
SCHEMBL19491793	0.94	SELE (0.79)	SELE
SCHEMBL17777179	0.94	SELE (0.79)	SELE
SCHEMBL17777238	0.94	SELE (0.79)	SELE
SCHEMBL19479268	0.94	SELE (0.79)	SELE
SCHEMBL19508731	0.94	SELE (0.79)	SELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20230365609-A1	HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS	GLYCOMIMETICS, INC. (US)	2023-11-16	—	—	US	disclosed
US-20230365609-A1	HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS	GLYCOMIMETICS, INC. (US)	2023-11-16	—	—	US	disclosed
US-11780873-B2	Highly potent multimeric e-selectin antagonists	GLYCOMIMETICS, INC. (US)	2023-10-10	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-11780873-B2	Highly potent multimeric e-selectin antagonists	SELE, SELP, SELPLG	SELE 1/4885
US-20230365609-A1	HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS	SELE, SELP, SELPLG	SELE 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.